POSTER SESSION II
Monday, March 19, 2012   —  1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


BREAST PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
40 Distinguishing Metastatic Neuroendocrine Tumors to the Breast from Primary Invasive Mammary Carcinomas with Neuroendocrine Differentiation (180)
S Kim, SK Mohanty, RB Mertens, S Bose, LJ Jih, D Dhall - Cedars-Sinai Medicine, Los Angeles, CA 		Add
41 Metastatic Non-Small Cell Lung Carcinoma (NSCLC) Masquerading as Primary Breast Cancer (PBC) – A Rare yet Major Pitfall in Pathologic Diagnosis (87)
R Ali, T Mohammad, M Hayes, D Ionescu - BC Cancer Agency, Vancouver, BC, Canada 		Add
42 The Spectrum of Osteosarcomatous and Chondrosarcomaous Differentiation in Malignant Breast Lesions (272)
CL Stephenson, JF Simpson, DL Page, ME Sanders - Vanderbilt University Medical Center, Nashville, TN 		Add
43 Morphologic & Immunohistochemical Heterogeneity in Mucinous Carcinoma of Breast (MC) (187)
ON Kryvenko, J Yoon, J Arias-Stella, MW Lee, DA Chitale - Henry Ford Hospital, Detroit, MI 		Add
44 Adenoid Cystic Carcinoma of the Breast – A Morphologic Study of 41 Cases (269)
EA Slodkowska, S Sahoo, M Akram, J Catalano, D Giri - Memorial Sloan Kettering Cancer Center, New York, NY; UT Southwestern Medical Center, Dallas 		Add
45 Breast Cancer Subtypes and Epigenetic Characterization of in Women from Senegal, West Africa (247)
M Rendi, KH Allison, J Stern, S Hawes, Q Feng, N Kiviat - University of Washington, Seattle 		Add
46 Tubulopapillary Carcinoma of Breast: A Distinct Entity? (184)
F Konno, J Cangiarella, L Chiriboga, S Krauter, F Darvishian - NYU Langone Medical Center, New York, NY 		Add
47 Diabetic Mastopathy, a Clinicopathological Correlation of 32 Cases (132)
O Dorokhova, S Fineberg, A Shapoval, T Koenigsberg, Y Wang - Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY; St. Vincent´s Medical Center, Bridgeport, CT 		Add
48 Breast Angiosarcoma: A Clinicopathologic Study (150)
AV Florea, DJ Dabbs, S Beriwal, R Bhargava - Jewish General Hospital/McGill University, Montreal, Canada; Magee-Womens Hospital/University of Pittsburgh Medical Center, Pittsburgh 		Add
49 Neuroendocrine Cell Hyperplasia of the Breast – Potential Precancerous Lesion of Mammary Neuroendocrine Carcinoma (177)
T Kawasaki, K Mochizuki, T Kondo, H Yamauchi, S Inoue, M Inoue, N Oishi, T Yamane, T Nakazawa, D Niu, K Nakazawa, Y Ishii, T Yuminamochi, H Yagata, H Tsunoda, H Onishi, H Fujii, R Katoh - University of Yamanashi, Yamanashi, Japan; St. Luke´s International Hospital, Tokyo, Japan 		Add
50 Lipophyllodes of the Breast. A Clinicopathologic Study of 10 Cases Integrated by Molecular Pathology Insights (190)
J Lamovec, P Cusati, S Pizzolitto, G De Maglio, G Falconieri - Institute of Oncology, Ljubljana, Slovenia; General University Hospital, Udine, Italy; General Hospital, Santiago do Cacem, Portugal 		Add
51 Breast Implant Capsule-Associated Anaplastic Large Cell Lymphoma (BIC-ALCL) (213)
C Mies, A Goyal, A Bagg, DM Frank, FG Barr, AL Dara, DB Roy, S Jaffer - Hospital of the University of Pennsylvania, Philadelphia, PA; Mount Sinai Medical Center, New York, NY 		Add
52 Metastatic Melanoma Presenting as Isolated Breast Tumor: A Study of 20 Cases (92)
CE Bacchi, SC Wludarski, AB Ambaye, J Lamovec, G Falconieri - Consultoria em Patologia, Botucatu, SP, Brazil; Institute of Oncology, Ljubljana, Slovenia; University of Vermont, Burlington, VT; General Hospital, Udine, Italy 		Add
53 VEGFA Amplification/Deletion in Human Breast Tumors (261)
BP Schneider, M Radovich, B Hancock, N Kassem, G Sledge, K Vang Nielsen, S Muller, M Thorat, R Mehta, S Badve - Indiana University School of Medicine, Indianapolis, IN; Dako A/S, Glostrup, Denmark 		Add
54 Identification of an Effective Immunohistochemical Panel in Distinction of Breast Carcinoma from Endometrial Adenocarcinoma (201)
H Liu, J Prichard, F Lin - Geisinger Medical Center, Danville, PA 		Add
55 Concordance between Tissue Microarray and Whole Section Estrogen Receptor Expression and Intratumoral Heterogeneity (135)
L Dvorak, R Gamez, L Varghese, C Forster, HE Gulbahce - University of Minnesota Fairview, Minneapolis, MN; Mayo Clinic, Rochester, MN; Fairview Southdale Hospital, Edina, MN; BioNet, University of Minnesota Fairview, Minneapolis, MN; VA Medical Center, Minneapolis, MN 		Add
56 Role of Beta-Catenin as a Mediator in the sFRP1-Induced Wnt Signaling and Epithelial-to-Mesenchymal Transition in Triple Negative Breast Cancer (166)
J Iqbal, AA Thike, PH Tan, MM Thu - Singapore General Hospital, Singapore 		Add
57 Expression of CK14, CK8/18 and IMP3 in BRCA-Related Invasive Breast Carcinomas (126)
F Dadmanesh, SK Mohanty, O Gordon, S Bose - Cedars-Sinai Medical Center, Los Angeles, CA 		Add
58 TOP2A Status in Chemotherapy-Treated Breast Cancer Patients Using FISH in Cytokertatin-Positve Cells (234)
WE Pierceall, J Bartek, J Bartkova, H Nevanlinna, C Blomqvist - On-Q-ity, Inc, Waltham, MA; Danish Cancer Society, Copenhagen, Denmark; Helsinki University Central Hospital, Helsinki, Finland 		Add
59 Role of HER4 in Trastuzumab Therapy Effectiveness for Metastatic Breast Cancer (214)
EC Minca, BP Portier, Z Wang, C Lanigan, E Downs-Kelly, RR Tubbs - Cleveland Clinic Foundation, Cleveland, OH 		Add
60 Comparison of Tumor Biomarkers in Primary Breast Carcinoma and Paired Metastases (216)
G Moses, Y Peng, Y Fang, S Sahoo, V Sarode - UT Southwestern Medical Center, Dallas, TX 		Add
61 Overexpression of EGFR and c-MET in Triple Negative Breast Cancer Is Associated with Poor Prognosis (293)
AK Witkiewicz, RL Lipinski, C Solomides, S Peiper - Thomas Jefferson University, Philadelphia, PA 		Add
62 Evaluation of Mesothelin and c-Met Expression in Triple Negative Breast Carcinomas Reveals Mesothelin as an Ideal, and Novel, Therapeutic Target (298)
R Xian, J Tchou, A Ziober, R Vonderheide, B Selvan, C June, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA 		Add
63 Reduced or Loss of ER and PR Receptor Expression in Metastatic Breast Cancer (160)
R Gupta, C Tornos, M Singh, B O´Hea, J Liu - Stony Brook University Medical Center, Stony Brook, NY 		Add
64 ERCC1 Expression and Complete Pathologic Response to Platinum-Based Therapy for Patients with Triple Negative Breast Cancer (115)
C Gomez-Fernandez, M Cioffi-Lavina, J Hurley, G Walker, JJ Hu, M Jorda - Jackson Memorial Hospital, Miami, FL; University of Miami School of Medicine, Miami, FL; Sylvester Comprehensive Cancer Center, Miami, FL 		Add
65 A 2-Marker IHC Panel of Nestin and INPP4B for Detection of Basal-Like Breast Cancer Defined by Gene Expression (112)
JR Choo, D Gao, G Chao, C Chow, S Aparicio, CM Perou, TO Nielsen - Genetic Pathology Evaluation Centre, Vancouver, Canada; University of British Columbia, Vancouver, Canada; University of North Carolina, NC 		Add
66 Tissue Microarrays as a Validation Methodology for Quality Control of HER2 Analysis by Fluorescence In Situ Hybridization (286)
LE Vasquez, D Canon, Y Abello, N Ospina, A Plata, MM Torres, RE Andrade - Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Universidad de los Andes, Bogotá, Colombia 		Add
67 Detection of Short Forms of HER2 in FFPE Specimens in Breast Cancer: Biological Significance and Impact on Patient Care (164)
J Huang - Medical College of Wisconsin, Milwaukee, WI 		Add
68 The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2 Expression in Invasive Breast Cancer (303)
IZ Yildiz-Aktas, DJ Dabbs, M Chivukula, R Bhargava - University of Pittsburgh Medical Center, PA 		Add
69 Controlling Preanalytic Variables Eliminates Her2 and Estrogen Receptor Status Discordance among 50 Paired Breast and Axillary Node Core Biopsies (104)
C Carter, JM Avent, RE Rosenthal, MEH Hammond, DV Miller - Intermountain Medical Center/LDS Hospital, Salt Lake City, UT 		Add
70 Comparison of HER-2 and Hormone Receptor (HR) Status between Primary Breast Cancer and Corresponding Distant Metastatic Sites with Double Check Assessment (152)
I Frahm, S Sarancone, G Acosta Haab, V Caceres - Sanatorio Mater Dei, Buenos Aires, Argentina; Laboratorio Quantum, Rosario, Argentina; Instituto Maria Curie, Buenos Aires, Argentina; Productos Roche, Buenos Aires, Argentina 		Add
71 The Effect of Prolonged Cold Ischemia Time on Estrogen Receptor Detection in Breast Cancer (197)
X Li, MT Deavers, M Guo, LP Middleton, P Liu, L Huo - The University of Texas, MDACC, Houston 		Add
72 Clinicopathologic and Genomic Characterization of Solid Papillary Breast Carcinoma (SPC) (136)
C Eberle, M Magbanua, E Sosa, J Grenert, JT Rabban, C Zaloudek, Y-Y Chen - University of California, San Francisco, San Francisco, CA 		Add
73 Immunophenotypic and Genomic Characterisation of Papillary Carcinomas of the Breast (134)
R Duprez, P Wilkerson, M Lacroix-Triki, MB Lambros, A Mackay, R A´Hern, A Gauthier, P-E Colombo, F Daley, R Natrajan, E Ward, G MacGrogan, F Arbion, P Michenet, B Weigelt, A Vincent-Salomon, JS Reis-Filho - The Institute of Cancer Research, London, United Kingdom; Institut Claudius Regaud, Toulouse, France; Institut Curie, Paris, France; Institut Bergonié, Bordeaux, France; Centre Hospitalier Universitaire, Tours, France; Centre Hospitalier Régional, Orléans, France; Cancer Research UK London Research Institute, London, United Kingdom 		Add
74 Integrative Analysis of Papillary Carcinomas of the Breast (251)
DN Rodrigues, P Wilkerson, R Duprez, A Mackay, MB Lambros, A Gauthier, O Mariani, M Mansour, R Natrajan, B Weigelt, A Vincent-Salomon, JS Reis-Filho - The Institute of Cancer Research, London, United Kingdom; Institut Curie, Paris, France; Cancer Research UK London Research Institute, London, United Kingdom 		Add
75 Identification of Fusion Genes in Papillary Carcinomas of the Breast (244)
JS Reis-Filho, A Mackay, PM Wilkerson, MB Lambros, A Gauthier, O Mariani, R Duprez, DN Rodrigues, M Mandour, C Maher, B Weigelt, R Natrajan, A Vincent-Salomon - The Institute of Cancer Research, London, United Kingdom; Institut Curie, Paris, France; Washington University in St Louis, St Louis; Cancer Research UK London Research Institute, London, United Kingdom 		Add
76 Adenoid Cystic Carcinoma of the Breast: Clinicopathologic and Molecular Analysis of 56 Cases (309)
X Zhu, J Chen, Y Xing, CT Albarracin, Y Zhao, PH Rao, X Li, D Bell, A El-Naggar, SC Abraham, Y Wu - UT MD Anderson Cancer Center, Houston; Cancer Hospital, Fudan University, Shanghai, China; Texas Children´s Hospital, Houston 		Add
77 MYB-NFIB Gene Fusion Is Present in Mammary Adenoid Cystic Carcinoma (ACC) and Cylindroma, Two Morphologically Similar Entities (122)
TM D´Alfonso, J Padilla, SJ Shin - Weill Cornell Medical College, New York, NY 		Add
78 Molecular Evidence in Support of the Neoplastic and Precursor Nature of Microglandular Adenosis (157)
FC Geyer, M Lacroix-Triki, P-E Colombo, N Patani, A Gauthier, R Natrajan, MB Lambros, I Khalifeh, C Albarracin, S Orru, C Marchio, A Sapino, A Mackay, B Weigelt, FC Schmitt, J Wesseling, N Sneige, JS Reis-Filho - Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Institut Claudius Regaud, Toulouse, France; CRLC Val d´Aurelle, Montpellier, France; The Institute of Cancer Research, London, United Kingdom; Institut Curie, Paris, France; The American University of Beirut Medical Center, Beirut, Lebanon; The University of Texas MD Anderson Cancer Centre, Houston; Ospedale A. Businco, Cagliari, Italy; University of Turin, Turin, Italy; Cancer Research UK London Research Institute, London, United Kingdom; Institute of Molecular Pathology and Immunology (IPATIMUP), Oporto, Portugal; Netherlands Cancer Institute, Amsterdam, Netherlands 		Add
79 Intra-Operative Margin Evaluation of Breast Specimens: Value of Gross Evaluation (206)
AR Mallon, DJ Dabbs, RR Johnson, GM Ahrendt, KP McGuire, M Bonaventura, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA 		Add